Sponsor

Netris Pharma

France 28 Rue Laennec, 69008 Lyon, France

About the sponsor

Netris Pharma’s clinical research is centered on advanced endometrial carcinoma and cervix carcinoma, with studies focused on patients whose disease has progressed or relapsed after prior systemic chemotherapy.

Locally advanced disease
Metastatic disease
Recurrent endometrial cancer
Recurrent cervical cancer

The sponsor’s interest in this area reflects a focus on difficult-to-treat gynecologic malignancies requiring new treatment options.

About Specializations

Netris Pharma runs clinical trials in conditions such as Endometrial cancer, Cervix carcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Endometrial cancer+1

Not recruiting

Registered drugNo placebo

Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Netris Pharma

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →